Announced details
Many companies use ZenmuTech’s proprietary products (number of companies: not disclosed)
AIHOBS and ZenmuTech jointly developed the secret-sharing proxy. Capital and personnel relationships: not disclosed.
Head office: Minato-ku, Tokyo; Representative Director: Hatta Yasuhide (八田泰秀). AIHOBS is a business company established to put into practical use the research and development results of the Healthcare AI Platform Technology Research Association (HAIP), which originated from Phase 2 of the Cabinet Office’s SIP. It aims to build an industry-wide platform connecting medical institutions with service providers.
Patent pending (application number and expiration date: Not disclosed)
5th Floor, Ichigo Shinkawa Building, 2-22-1 Shinkawa, Chuo-ku, Tokyo
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Digital Trust Grid, Secret-sharing proxy, ZENMU-AONT |
| Counterparty | 株式会社AIHOBS |
| Counterparty overview | Head office: Minato-ku, Tokyo; Representative Director: Hatta Yasuhide (八田泰秀). AIHOBS is a business company established to put into practical use the research and development results of the Healthcare AI Platform Technology Research Association (HAIP), which originated from Phase 2 of the Cabinet Office’s SIP. It aims to build an industry-wide platform connecting medical institutions with service providers. |
| Relationship with the Company | AIHOBS and ZenmuTech jointly developed the secret-sharing proxy. Capital and personnel relationships: not disclosed. |
| Applicable area | Medical AI applications, Data sharing among medical institutions, Medical data distribution, Real-world data utilization |
| Registration number and expiry date | Patent pending (application number and expiration date: Not disclosed) |
| Location | 5th Floor, Ichigo Shinkawa Building, 2-22-1 Shinkawa, Chuo-ku, Tokyo |
| Usage history | Many companies use ZenmuTech’s proprietary products (number of companies: not disclosed) |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The implementation is intended to address ransomware attacks targeting medical institutions and information leaks, establish a secure infrastructure for medical data distribution, and overcome the limitations of conventional methods that rely on encryption-key management.